Quantcast

Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010

September 7, 2010

SAN DIEGO, Sept. 7 /PRNewswire-FirstCall/ — Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:


            Morgan Stanley Global Healthcare
    --      Conference
           Date:  Tuesday, September 14, 2010
            Time:  10:55am Eastern Time (7:55am
            Pacific Time)
            Place:  Grand Hyatt Hotel in New York
            City
            Speaker:  Ted Schroeder, President &
            CEO

            Stifel Nicolaus Healthcare Conference
       --   2010
           Date:  Thursday, September 16, 2010
            Time:  8:00am Eastern Time (5:00am
            Pacific Time)
           Place:  Four Seasons Hotel in Boston
            Speaker:  Ted Schroeder, President &
            CEO

       --  UBS Global Life Sciences Conference
           Date:  Wednesday, September 22, 2010
            Time:  10:00am Eastern Time (7:00am
            Pacific Time)
            Place:  Grand Hyatt Hotel in New York
            City
           Speaker:  William R. LaRue, SVP & CFO

       --  JMP Securities Healthcare Conference
           Date:  Monday, September 27, 2010
            Time:  10:00am Eastern Time (7:00am
            Pacific Time)
            Place:  The New York Palace Hotel in
            New York City
            Speaker:  Ted Schroeder, President &
            CEO

Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals’ website at www.cadencepharm.com on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.


    Contacts:   William R. LaRue
                SVP, CFO
                Cadence Pharmaceuticals, Inc.
                858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.


Source: newswire



comments powered by Disqus